Literature DB >> 22350412

Jab1/CSN5 negatively regulates p27 and plays a role in the pathogenesis of nasopharyngeal carcinoma.

Yunbao Pan1, Qingxiu Zhang, Ling Tian, Xin Wang, Xiaohang Fan, Huizhong Zhang, Francois X Claret, Huiling Yang.   

Abstract

Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus-associated malignancy most common in East Asia and Africa. Aberrant expression of Jab1/CSN5, a negative regulator of the cell-cycle inhibitor p27, is correlated with reduced p27 expression and associated with advanced tumor stage and poor prognosis in several human cancers. In this study, we examined the functional relationship between Jab1 and p27 protein expression in NPC. Immunohistochemical analysis showed an inverse association between Jab1 and p27 in NPC tissue samples, and overexpression of Jab1 correlated with poor survival in patients with NPC. Mechanistically, Jab1 and p27 were found to interact directly in NPC cells, with Jab1 mediating p27 degradation in a proteasome-dependent manner. Knockdown of Jab1 resulted in a remarkable increase in p27 levels and inhibition of cell proliferation, indicating that Jab1 targets p27 for degradation, thereby controlling its stability. Jab1 depletion also enhanced the antitumor effects of cisplatin in NPC cells. Together, our findings suggest that Jab1 overexpression plays an important role in the pathogenesis of NPC through Jab1-mediated p27 degradation. Jab1 therefore represents a novel diagnostic marker and therapeutic target in patients with NPC. ©2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22350412      PMCID: PMC3460549          DOI: 10.1158/0008-5472.CAN-11-3472

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  36 in total

1.  Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1.

Authors:  K Tomoda; Y Kubota; J Kato
Journal:  Nature       Date:  1999-03-11       Impact factor: 49.962

2.  Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer.

Authors:  Corinne Dahinden; Barbara Ingold; Peter Wild; Gunther Boysen; Van-Duc Luu; Matteo Montani; Glen Kristiansen; Tullio Sulser; Peter Bühlmann; Holger Moch; Peter Schraml
Journal:  Clin Cancer Res       Date:  2009-12-22       Impact factor: 12.531

3.  Treatment of stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation.

Authors:  Anne W M Lee; T K Yau; Dominique H M Wong; Elian W K Chan; Rebecca M W Yeung; W T Ng; Macy Tong; Inda S Soong; W M Sze
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-19       Impact factor: 7.038

4.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

Authors:  H Toyoshima; T Hunter
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

5.  Jun activation domain-binding protein 1 expression in malignant lymphoma of the thyroid: its linkage to degree of malignancy and p27 expression.

Authors:  Yasuhiro Ito; Hiroshi Yoshida; Fumio Matsuzuka; Nariaki Matsuura; Yasushi Nakamura; Hirokazu Nakamine; Kennichi Kakudo; Kanji Kuma; Akira Miyauchi
Journal:  Anticancer Res       Date:  2003 Sep-Oct       Impact factor: 2.480

6.  JAB1/CSN5: a new player in cell cycle control and cancer.

Authors:  Terry J Shackleford; Francois X Claret
Journal:  Cell Div       Date:  2010-10-18       Impact factor: 5.130

7.  Overexpression of cyclin E messenger ribonucleic acid in nasopharyngeal carcinoma correlates with poor prognosis.

Authors:  M-T Ko; C-Y Su; S-C Huang; C-H Chen; C-F Hwang
Journal:  J Laryngol Otol       Date:  2009-03-11       Impact factor: 1.469

8.  Design of a prognostic index score for metastatic nasopharyngeal carcinoma.

Authors:  Y K Ong; D M Heng; B Chung; S S Leong; J Wee; K W Fong; T Tan; E H Tan
Journal:  Eur J Cancer       Date:  2003-07       Impact factor: 9.162

Review 9.  The COP9 signalosome.

Authors:  Ning Wei; Xing Wang Deng
Journal:  Annu Rev Cell Dev Biol       Date:  2003       Impact factor: 13.827

Review 10.  Nasopharyngeal carcinomas: an update.

Authors:  J-P Spano; P Busson; D Atlan; J Bourhis; J-P Pignon; C Esteban; J-P Armand
Journal:  Eur J Cancer       Date:  2003-10       Impact factor: 9.162

View more
  34 in total

Review 1.  The emerging roles of Jab1/CSN5 in cancer.

Authors:  Lin Wang; Jun-Nian Zheng; Dong-Sheng Pei
Journal:  Med Oncol       Date:  2016-07-13       Impact factor: 3.064

2.  Jab1/Csn5-Thioredoxin Signaling in Relapsed Acute Monocytic Leukemia under Oxidative Stress.

Authors:  Fuling Zhou; Yunbao Pan; Yongchang Wei; Ronghua Zhang; Gaigai Bai; Qiuju Shen; Shan Meng; Xiao-Feng Le; Michael Andreeff; Francois X Claret
Journal:  Clin Cancer Res       Date:  2017-03-07       Impact factor: 12.531

3.  Jab1 promotes glioma cell proliferation by regulating Siah1/β-catenin pathway.

Authors:  Yufu Zhu; Zhichao Qiu; Xiang Zhang; Fengyuan Qian; Bin Wang; Lei Wang; Hengliang Shi; Rutong Yu
Journal:  J Neurooncol       Date:  2016-09-17       Impact factor: 4.130

4.  Functional characterization of TRPM7 in nasopharyngeal carcinoma and its knockdown effects on tumorigenesis.

Authors:  Yi Qin; Zhi-Wei Liao; Jing-Yan Luo; Wen-Zhe Wu; An-Shang Lu; Pu-Xia Su; Bing-Quan Lai; Xiao-Xiao Wang
Journal:  Tumour Biol       Date:  2016-01-15

Review 5.  Emerging roles of Jab1/CSN5 in DNA damage response, DNA repair, and cancer.

Authors:  Yunbao Pan; Huiling Yang; Francois X Claret
Journal:  Cancer Biol Ther       Date:  2014-02-04       Impact factor: 4.742

Review 6.  Targeting Jab1/CSN5 in nasopharyngeal carcinoma.

Authors:  Yunbao Pan; Francois X Claret
Journal:  Cancer Lett       Date:  2012-08-04       Impact factor: 8.679

Review 7.  Jab1/Cops5: a promising target for cancer diagnosis and therapy.

Authors:  Chunjue Yuan; Dong Wang; Guohong Liu; Yunbao Pan
Journal:  Int J Clin Oncol       Date:  2021-05-21       Impact factor: 3.402

8.  NT157 Inhibits HCC Migration via Downregulating the STAT3/Jab1 Signaling Pathway.

Authors:  SiZhe Yu; Yu Wang; KeJia Lv; Jia Hou; WenYuan Li; Xiao Wang; Hui Guo; WenJuan Wang
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

9.  Identification of a seven-long non-coding RNA signature associated with Jab1/CSN5 in predicting hepatocellular carcinoma.

Authors:  Weijie Ma; Ye Yao; Gang Xu; Xiaoling Wu; Jinghua Li; Ganggang Wang; Xi Chen; Kunlei Wang; Yirang Chen; Yonghua Guo; Yongsheng Li; Deli Tan; Hui Guo; Zhisu Liu; Yufeng Yuan; Francois X Claret
Journal:  Cell Death Discov       Date:  2021-07-10

Review 10.  Current approach and novel perspectives in nasopharyngeal carcinoma: the role of targeting proteasome dysregulation as a molecular landmark in nasopharyngeal cancer.

Authors:  Ramon Yarza; Mateo Bover; Maria Teresa Agulló-Ortuño; Lara Carmen Iglesias-Docampo
Journal:  J Exp Clin Cancer Res       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.